In the latest round of Phase 3 RECONNECT studies, the newest compound, bremelanotide was tested on premenopausal women suffering from HSDD
Over-the-counter pain relief may be appropriate for managing acute headaches
In this short review video, our clinical team walks you through the updated layout, clearer visuals, and streamlined interpretation tools designed to make your assessments faster and more intuitive
Retatrutide, developed by Eli Lilly under the code LY3437943, is a synthetic peptide that simultaneously activates three incretin and metabolic receptors: GLP-1, GIP, and glucagon
Chronic hyperglycemia and cardiovascular dysfunction: an in-depth exploration of metabolic and cellular pathways in type 2 diabetes mellitus